TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ACIU

AC Immune Ltd

Healthcare · Biotechnology

2.50$ -5.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

AC Immune Ltd (ACIU) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -66 million CHF. Tick rows to compare them in a chart.

All figures in millions of CHF.

Tick rows to compare them in a chart (up to 4)

Cash Flow ACIU
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-18 44 -5.6 -22 -44 55 -60 -66 -74 -60 66 -66
0.3 0.3 0.3 0.6 1.0 1.7 2.0 2.4 2.4 2.2 2.2 2.4
0.2 0.5 1.3 1.6 2.5 2.8 4.1 4.1 3.3 4.4 5.5 4.4
0.4 -1.4 -1.9 6.1 4.1 2.4 5.0 -1.9 3.3 – – –
-29 25 3.3 -2.0 1.8 5.7 -4.6 6.8 -8.4 -15 108 -6.5
0.1 0.2 0.9 1.8 1.9 1.9 1.7 2.6 1.2 0.8 0.6 0.9
-0.1 -0.2 -0.9 -1.8 -32 -67 28 -54 24 66 -105 61
0.0 0.0 0.0 0.0 0.0 0.0 – – 0.0 – – –
10 30 83 0.1 112 0.1 -0.1 0.0 0.0 – – –
0.2 0.2 0.2 0.2 -0.1 50 -0.9 23 -0.6 -0.5 -0.7 -1.0
9.8 28 79 0.3 109 50 -0.8 41 -1.3 43 -1.1 -1.0
-7.9 73 76 -28 32 37 -33 -79 -51 47 -42 -4.9
-18 44 -6.5 -24 -46 53 -61 -68 -75 -61 65 -67

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?